Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

OptimizeRx (OPRX) Other Operating Expenses (2016 - 2026)

OptimizeRx's Other Operating Expenses history spans 16 years, with the latest figure at $15.5 million for Q4 2025.

  • On a quarterly basis, Other Operating Expenses fell 15.54% to $15.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $18.8 million, a 35.5% decrease, with the full-year FY2025 number at $11.6 million, down 50.14% from a year prior.
  • Other Operating Expenses hit $15.5 million in Q4 2025 for OptimizeRx, up from $1.1 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for OPRX hit a ceiling of $18.4 million in Q4 2024 and a floor of -$8.6 million in Q1 2023.
  • Historically, Other Operating Expenses has averaged $3.6 million across 5 years, with a median of $1.1 million in 2025.
  • The widest YoY moves for Other Operating Expenses: up 2075.92% in 2023, down 1930.6% in 2023.
  • Tracing OPRX's Other Operating Expenses over 5 years: stood at -$7.1 million in 2021, then skyrocketed by 326.9% to $16.2 million in 2022, then plummeted by 91.72% to $1.3 million in 2023, then surged by 1270.27% to $18.4 million in 2024, then dropped by 15.54% to $15.5 million in 2025.
  • Business Quant data shows Other Operating Expenses for OPRX at $15.5 million in Q4 2025, $1.1 million in Q3 2025, and $1.1 million in Q2 2025.